Page last updated: 2024-10-29
indirubin-3'-monoxime and Constriction, Pathological
indirubin-3'-monoxime has been researched along with Constriction, Pathological in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Schwaiberger, AV | 1 |
| Heiss, EH | 1 |
| Cabaravdic, M | 1 |
| Oberan, T | 1 |
| Zaujec, J | 1 |
| Schachner, D | 1 |
| Uhrin, P | 1 |
| Atanasov, AG | 1 |
| Breuss, JM | 1 |
| Binder, BR | 1 |
| Dirsch, VM | 1 |
Other Studies
1 other study available for indirubin-3'-monoxime and Constriction, Pathological
| Article | Year |
|---|---|
Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
Topics: Animals; Arterial Occlusive Diseases; Becaplermin; Cell Cycle; Cell Proliferation; Cells, Cultured; | 2010 |